Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections
DT Lounder, Q Bin, C de Min, MB Jordan - Blood Advances, 2019 - Elsevier
DT Lounder, Q Bin, C de Min, MB Jordan
Blood Advances, 2019•ElsevierMethods Clinical data are from the Cincinnati Children's Hospital clinical laboratories.
Chemokine levels were measured by Novimmune via MSD, a Meso Scale Discovery assay.
Parental consent was obtained for participation in institutional review board–approved
research studies, per the Declaration of Helsinki.
Chemokine levels were measured by Novimmune via MSD, a Meso Scale Discovery assay.
Parental consent was obtained for participation in institutional review board–approved
research studies, per the Declaration of Helsinki.
Methods
Clinical data are from the Cincinnati Children's Hospital clinical laboratories. Chemokine levels were measured by Novimmune via MSD, a Meso Scale Discovery assay. Parental consent was obtained for participation in institutional review board–approved research studies, per the Declaration of Helsinki.
Elsevier
